Allergan has announced that the latest addition to the JUVÉDERM collection of fillers, JUVÉDERM VOLBELLA XC, is now available to physicians and patients for use in the lips for lip augmentation and for correction of perioral rhytides in adults over the age of 21.

In clinical trials, the filler was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year. The most common side effects observed were temporary responses at the treatment site such as swelling, tenderness, bruising, firmness, lumps/bumps, redness, pain, discoloration, itching and dryness. Most resolved within 30 days.

“Our physician customers have told us perioral lines are difficult to treat and are also a top concern among patients,” said David Nicholson, chief R&D officer at Allergan. “We developed a soft, smooth gel appropriate for adding subtle volume to the lips and softening the appearance of perioral lines to address this specific need.”

JUVÉDERM VOLBELLA XC is now available for purchase by physicians who have completed an online training program. For more information, visit www.volbellatraining.com.

More in Business